ARCHIVES

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

This article is from The Cancer Letter archive.

Vol. 25 No. 05 | February 5, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

Harkin Withdraws Amendment Allow NIH To Bypass INDS

October 9, 1992

Hatch Introduces Bill to Modify Delaney Amendment

June 13, 1986

In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB

April 4, 1975

Weinberger, Edwards Back Away From Fight Over NCI’s Independence, Ask For Authorization Figures To Be Dropped

February 8, 1974

NCI Advisory Group, Other Cancer Meetings

August 26, 1977